Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly

Condition:   Acromegaly Intervention:   Drug: BIM23B065 Sponsor:   Ipsen Recruiting - verified February 2017

Source: ClinicalTrials.gov - November 10, 2016 Category: Research Source Type: clinical trials